Early results of infrageniculate arterial reconstruction using cryopreserved homograft saphenous conduit (CADVEIN) and combination low-dose systemic immunosuppression

Journal of the American College of Surgeons

Volumn 183, Issue 3, 1996, Pages 208-216

  Posner, Marc P ^a   Makhoul, Raymond G ^a   Altman, Marian ^a   Kimball, Pamela ^a   Cohen, Neri ^a   Sobel, Michael ^a   Dattilo, Jeffery ^a   Lee, H M ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; CYCLOSPORIN A; PREDNISONE; VASODILATOR AGENT; WARFARIN;

ADULT; AGED; ALLOGRAFT; ANASTOMOSIS DEHISCENCE; ANEURYSM; ANTICOAGULANT THERAPY; ARTERY RECONSTRUCTION; ARTICLE; CLINICAL ARTICLE; CRYOPRESERVATION; FEMALE; GRAFT PATENCY; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MORBIDITY; PRIORITY JOURNAL; SAPHENOUS VEIN; VEIN GRAFT;

ADULT; AGED; BLOOD VESSEL PROSTHESIS; CRYOPRESERVATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIFE TABLES; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; SAPHENOUS VEIN; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; VASCULAR PATENCY; VASODILATOR AGENTS;

EID: 0029773654     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Taylor, R. S., Loh, A., McFarland, R. J., and others. Improved technique for polytetrafluoroethylene bypass grafting: long-term results using anastomotic vein patches. Br. J. Surg., 1992, 79: 348-354.
2. Hobson II, R. W., Lynch, T. G., Jamil, Z., and others. Results of revascularization and amputation in severe lower extremity ischemia: a five year clinical experience. J. Vasc. Surg., 1985, 2: 174-185.
3. Veith, F. J., Gupta, S. K., Ascer, E., and others. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J. Vasc. Surg., 1986, 3: 104-114.
4. Whittemore, A. D., Craig Kent, K., Donaldson, M. C., and others. What is the proper role of polytetrafluoroethylene grafts in infra-inguinal reconstruction? J. Vasc. Surg., 1989, 10: 299-305.
5. Christenson, J. T., Broome, A., Nogren, L., and Eklof, B. Revascularization of popliteal and below-knee arteries with polytetrafluoroethylene. Surgery, 1985, 97: 141-149.
6. Brockbank, K. G. M. Effects of cryopreservation upon vein function in vivo. Cryobiology, 1994, 31: 71-81.
7. Brockbank, K. G. M., McNally, R. T., and Walsh, K. A. Cryopreserved vein transplantation. J. Cardiac Surg., 1992, 7: 170-176.
8. Harris, R. W., Schneider, P. A., Andros, G., and others. Allograft vein bypass: is it an acceptable alternative for infrapopliteal revascularization? J. Vasc. Surg., 1993, 18: 553-560.
9. Senkowsky, J., Libke, M., Arellano, H., and others. Cryopreserved vein: an alternative to native vein in difficult lower extremity bypass. Presented at The International Society for Cardiovascular Surgery, XXI World Congress, September 12-15, 1993, Lisbon, Portugal.
10. Shah, R. M., Faggioli, G. L., Harris, L. M., and others. Cryopreserved saphenous vein allografts for infra-inguinal bypass. Presented at The International Society for Cardiovascular Surgery, XXI World Congress, September 12-15, 1993, Lisbon, Portugal.
11. Sellke, F. W., Meng, R. L., and Rossi, N. P. Cryopreserved saphenous vein homografts for femoral-distal vascular reconstruction. J. Cardiovasc. Surg., 1989, 30: 838-842.
12. Iliopoulos, J. I., Lowe, B., Hermreck, A. S., and others. Failure of cryopreserved saphenous vein allografts following infrainguinal arterial reconstructions. J. Vasc. Surg., 1993, 18: 533.
13. Martin, R. S., Edwards, W. H., Mulherin, J. L., and others. Cryopreserved saphenous vein allografts for below knee lower extremity revascularization. Ann. Surg., 1994, 219: 664-672.
14. Walker, P. J., Mitchell, R. S., McFadden, M., and others. Early experience with cryopreserved saphenous vein allografts as a conduit for complex limb-salvage procedures. J. Vasc. Surg., 1993, 18: 561-569.
15. Shah, R. M., Faggioli, G. L., Mangione, S., and others. Early results with cryopreserved saphenous vein allografts for infrainguinal bypass. J. Vasc. Surg., 1993, 18: 965-971.
16. Posner, M. P., and McNeill, P. M. Fate of cyclosporine-pretreated cryopreserved canine venous allografts in the arterial system. Surg. Forum, 1989, 40: 304-306.
17. Miller, V. M., Bergman, R. T., Gloviczki, P., and others. Cryopreserved venous allografts: effects of immunosuppression and antiplatelet therapy on patency and function. J. Vasc. Surg., 1993, 18: 216-226.
18. Schmitz-Rixen, T., Megerman, J., Colvin, R. B., and others. Immunosuppressive treatment of aortic allografts. J. Vasc. Surg., 1988, 7: 82-92.
19. Bandlien, K. O., Toledo-Pereyra, L. H., Mackenzie, G. H., and others. Immunosuppression with cyclosporine: a new approach to improve patency of venous allografts. Arch. Surg., 1983, 118: 829-833.
20. King, A. L., Brown, K. B., Lee, H. M., and others. Renal Transplantation in the Elderly - A Modern Series. Poster Session, American Society of Transplant Physicians Meeting, 1992, Chicago, IL.
21. Shaw, B. W. Transplantation in the elderly patient. Surg. Clin. North Am., 1994, 74: 389-400.
22. Ochsner, J. L., Lawson, J. D., Eskind, S. J., and others. Homologous veins as an arterial substitute: long-term results. J. Vasc. Surg., 1984, 1: 306-313.
23. Ricotta, J. J., Collins, G. J., Rich, N. M., and others. Failure of immunosuppression to prolong venous allograft survival. Arch. Surg., 1980, 115: 99-101.
24. Halloran, P., Schlaut, J., Solez, K., and Srinuvasa, N. The significance of the anti-class I response - clinical and pathologic features of renal transplants with anti-class I-like activity. Transplantation, 1992, 53: 550.
25. Cooper, T., Jordan, C., Willimon, C., and Land, G. Comparison of panel reactive antibody levels in Caucasian and African-American renal transplant candidates. Transplantation, 1995, 60: 327.
26. Kerman, R., Kimball, P., Van Buren, C., and other. AHG and DTE/AHG procedure - identification of crossmatch appropriate donor-recipient pairings that result in improved graft survival. Transplantation. 1991, 51: 316.
27. Ten Hoor, G., Coopmans, M., and Allebes, W. Specificity and Ig class of preformed alloantibodies causing a positive crossmatch in renal transplantation. Transplantation, 1993, 56: 298.
28. Karuppan, S., Ohlman, S., and Moller, E. The occurrence of cytotoxic and non-complement Fixing antibodies in the crossmatch serum of patients with early acute rejection episodes. Transplantation, 1992, 54: 839.
29. Ogura, K., Terasaki, P., Johnson, C., and other. The significance of a positive flow cytometry crossmatch test in primary kidney transplantation. Transplantation, 1993, 56: 294.
30. Perloff, L. J., Reckard, C. R., Rowlands, D. T., and others. The venous homograft: An immunological question. Surgery, 1972, 72: 961-970.
31. Williams, G. M., ter Haar, A., Krajewski, C., and others. Rejection and repair of endothelium in major vessel transplants. Surgery, 1975, 78: 694-706.
32. LoGerfo, F. W., Quist, W. C., Cantelmo, N. L., and others. Integrity of vein grafts as a function of initial intimal and medial preservation. Circulation, 1983, 68: 117-124.
33. Brockbank, K. G. M., Donovan, T. J., Ruby, S. T., and others. Functional analysis of cryopreserved veins - preliminary report. J. Vasc. Surg., 1990, 11: 94-102.
34. Showalter, D., Durham, S., Sheppeck, R., and others. Cryopreserved venous homografts as vascular conduits in canine carotid arteries. Surgery, 1989, 106: 652-659.
35. Sitzmann, J. V., Imbembo, A. L., Ricotta, J. J., and others. Dimethylsulfoxide-treated, cryopreserved venous allografts in the arterial and venous systems. Surgery, 1984, 85: 154-159.
36. Ricotta, J. J., Schaff, H. V., Gadacz, T. R., and others. The effect of aspirin and dipyridamole on the patency of allograft veins. J. Surg. Res., 1979, 26: 262-269.
37. Posner, M. P., Henriques, H., King, A. L., and others. Comparison of sequential combination immunotherapy for cadaveric renal transplantation: Prophylactic OKT3 vs Rabbit ATG. In: Organ Transplantation 1990. Edited by G. Abouna. Pp. 83-90. Boston: Kluwer Academic Publishing Co., 1991.
38. Moyer, T. P., Post, G. R., Sterioff, S., and others. Cyclosporine nephrotoxicity is minimized by adjusting dosage on the basis of drug concentration in blood. Mayo Clin. Proc., 1988, 63: 241-247.
39. Petersen, M. J., Abbott, W. M., H'Doubler, P. B., and others. Hemodynamics and aneurysm development in vascular allografts. J. Vasc. Surg., 1993, 18: 955-964.